Located in its San Diego facility, the new line will function within a Restricted Access Barrier System (RABS) and generate batch sizes of over 100,000 units. It will enable syringes to be filled under vacuum and includes weight checks to curtail product loss.
Having filled syringes for over eight years, “the addition of this new line allows us to continue to meet client requirements as they progress from late stage development through commercialisation” said Rich Hancock, President of Contract Manufacturing Services at Althea.
Prefilled syringes are said to benefit patient compliance and product differentiation. In the midst of an expanding market, the new line will enable clients to “quickly develop, register and launch their products in prefilled syringes” added Althea CEO Shabbir Anik.